News | August 25, 2025
Briefs: Mankind Pharma, Mangalam Drugs and Organics, Veerhealth Care and Shelter Pharma
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
Mangalam Drugs and Organics Limited has reported standalone financial results for the period ended December 31, 2021
This will enable Mangalam to reduce its reliability on Chinese imports for this product and also help to maintain an uninterrupted supply chain to a great extent
Subscribe To Our Newsletter & Stay Updated
